Amalgamated Bank cut its holdings in HCA Healthcare Inc (NYSE:HCA) by 2.9% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 39,924 shares of the company’s stock after selling 1,206 shares during the period. Amalgamated Bank’s holdings in HCA Healthcare were worth $5,554,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of HCA. First Trust Advisors LP raised its holdings in shares of HCA Healthcare by 68.9% in the second quarter. First Trust Advisors LP now owns 336,146 shares of the company’s stock valued at $34,489,000 after purchasing an additional 137,129 shares during the last quarter. Jennison Associates LLC acquired a new stake in shares of HCA Healthcare in the second quarter valued at approximately $2,231,000. Alps Advisors Inc. raised its holdings in shares of HCA Healthcare by 170.3% in the second quarter. Alps Advisors Inc. now owns 14,999 shares of the company’s stock valued at $1,539,000 after purchasing an additional 9,449 shares during the last quarter. Barings LLC raised its holdings in shares of HCA Healthcare by 184.9% in the second quarter. Barings LLC now owns 20,230 shares of the company’s stock valued at $2,075,000 after purchasing an additional 13,130 shares during the last quarter. Finally, Virginia Retirement Systems ET AL acquired a new stake in shares of HCA Healthcare in the second quarter valued at approximately $1,662,000. Institutional investors own 69.94% of the company’s stock.

NYSE:HCA opened at $135.86 on Monday. HCA Healthcare Inc has a 1-year low of $84.13 and a 1-year high of $147.42. The firm has a market capitalization of $46.76 billion, a P/E ratio of 20.62, a PEG ratio of 1.19 and a beta of 0.52.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, October 30th. The company reported $2.16 EPS for the quarter, topping the Zacks’ consensus estimate of $1.93 by $0.23. HCA Healthcare had a net margin of 6.82% and a negative return on equity of 73.71%. The firm had revenue of $11.45 billion during the quarter, compared to analysts’ expectations of $11.29 billion. During the same period in the previous year, the business posted $1.13 earnings per share. The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. On average, research analysts anticipate that HCA Healthcare Inc will post 9.34 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 28th. Shareholders of record on Monday, December 3rd will be given a dividend of $0.35 per share. The ex-dividend date is Friday, November 30th. This represents a $1.40 dividend on an annualized basis and a yield of 1.03%. HCA Healthcare’s dividend payout ratio (DPR) is 21.24%.

In other HCA Healthcare news, SVP Deborah M. Reiner sold 723 shares of HCA Healthcare stock in a transaction on Monday, November 5th. The shares were sold at an average price of $135.06, for a total transaction of $97,648.38. Following the completion of the transaction, the senior vice president now directly owns 6,184 shares of the company’s stock, valued at $835,211.04. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Kathryn A. Torres sold 820 shares of HCA Healthcare stock in a transaction on Tuesday, November 13th. The stock was sold at an average price of $142.36, for a total transaction of $116,735.20. Following the transaction, the senior vice president now directly owns 4,237 shares of the company’s stock, valued at $603,179.32. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 16,763 shares of company stock valued at $2,346,147. Company insiders own 2.80% of the company’s stock.

HCA has been the subject of several analyst reports. Credit Suisse Group raised their target price on shares of HCA Healthcare from $156.00 to $165.00 and gave the company an “outperform” rating in a research note on Thursday, November 1st. Jefferies Financial Group raised their target price on shares of HCA Healthcare to $155.00 and gave the company a “buy” rating in a research note on Friday, September 21st. SunTrust Banks raised their target price on shares of HCA Healthcare to $150.00 and gave the company a “positive” rating in a research note on Tuesday, September 4th. Morgan Stanley raised their target price on shares of HCA Healthcare from $115.00 to $124.00 and gave the company an “underweight” rating in a research note on Wednesday, September 5th. Finally, Zacks Investment Research cut shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Tuesday, November 27th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $144.15.

WARNING: “Amalgamated Bank Sells 1,206 Shares of HCA Healthcare Inc (HCA)” was published by Daily Political and is the property of of Daily Political. If you are reading this piece on another site, it was stolen and republished in violation of United States & international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.dailypolitical.com/2018/12/10/amalgamated-bank-sells-1206-shares-of-hca-healthcare-inc-hca.html.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

See Also: Understanding each part of a balance sheet

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.